{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T18:36:20Z","timestamp":1792866980425,"version":"4.5.0"},"reference-count":59,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T00:00:00Z","timestamp":1665878400000},"content-version":"vor","delay-in-days":288,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in record time to cope with the ongoing coronavirus disease 2019 (COVID-19) pandemic has led to uncertainty about their use and the appearance of adverse neurological reactions. The SARS-CoV-2 spike protein (SP) is used to produce neutralizing antibodies and stimulate innate immunity. However, considering the alterations in the nervous system (NS) caused by COVID- 19, cross-reactions are plausible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To identify peptides in\n                      <jats:italic toggle=\"yes\">Homo sapiens<\/jats:italic>\n                      SP-like proteins involved in myelin and axon homeostasis that may be affected due to molecular mimicry by antibodies and T cells induced by interaction with SP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      A bioinformatics approach was used. To select the\n                      <jats:italic toggle=\"yes\">H. sapiens<\/jats:italic>\n                      proteins to be studied, related biological processes categorized based on gene ontology were extracted through the construction of a protein\u2013protein interaction network. Peripheral myelin protein 22, a major component of myelin in the peripheral nervous system, was used as the query protein. The extracellular domains and regions susceptible to recognition by antibodies were extracted from UniProt. In the study of T cells, linear sequence similarity between\n                      <jats:italic toggle=\"yes\">H. sapiens<\/jats:italic>\n                      proteins and SP was assessed using BLASTp. This study considered the similarity in terms of biochemical groups per residue and affinity to the human major histocompatibility complex (human leukocyte antigen I), which were evaluated using Needle and NetMHCpan 4.1, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A large number of shared pentapeptides between SP and\n                      <jats:italic toggle=\"yes\">H. sapiens<\/jats:italic>\n                      proteins were identified. However, only a small group of 39 proteins was linked to axon and myelin homeostasis. In particular, some proteins, such as phosphacan, attractin, and teneurin-4, were susceptible targets of B and T cells. Other proteins closely related to myelin components in the NS, such as myelin-associated glycoprotein, were found to share at least one pentamer with SP in extracellular domains.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Proteins involved in the maintenance of nerve conduction in the central and peripheral NS were identified in\n                      <jats:italic toggle=\"yes\">H. sapiens<\/jats:italic>\n                      . Based on these findings, re-evaluation of the vaccine composition is recommended to prevent possible neurological side effects.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.csbj.2022.10.022","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T22:30:31Z","timestamp":1666823431000},"page":"6041-6054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Molecular Mimicry of SARS-CoV-2 Spike Protein in the Nervous System: A Bioinformatics Approach"],"prefix":"10.34133","volume":"20","author":[{"given":"Andr\u00e9s","family":"Felipe Cuspoca","sequence":"first","affiliation":[{"name":"Grupo de Investigaci\u00f3n en Neurociencias (NeURos), Centro de Neurociencia Neurovitae, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogot\u00e1, DC, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Isaac Estrada","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n en Neurociencias (NeURos), Centro de Neurociencia Neurovitae, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogot\u00e1, DC, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Velez-van-Meerbeke","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n en Neurociencias (NeURos), Centro de Neurociencia Neurovitae, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogot\u00e1, DC, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.33588\/rn.7009.2020179","article-title":"Neurological complications of coronavirus and COVID-19","volume":"70","author":"Carod-Artal F.J.","year":"2020","unstructured":"Carod-Artal F.J.: Neurological complications of coronavirus and COVID-19. Rev Neurol 2020; 70: 311.","journal-title":"Rev Neurol"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17186688","article-title":"Neurological complications of COVID-19 and possible neuroinvasion pathways: a systematic review","volume":"17","author":"Orr\u00f9 G.","year":"2020","unstructured":"Orr\u00f9 G., Conversano C., Malloggi E., Francesconi F., Ciacchini R., Neurological G.A. et al: Neurological complications of COVID-19 and possible neuroinvasion pathways: a systematic review. Int J Environ Res Public Health 2020; 17.","journal-title":"Int J Environ Res Public Health"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51166"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12974-021-02293-x","article-title":"Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases","volume":"18","author":"Vasilevska V.","year":"2021","unstructured":"Vasilevska V., Guest P.C., Bernstein H.G., Schroeter M.L., Geis C. and Steiner J.: Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases. J Neuroinflammation 2021; 18: 245.","journal-title":"J Neuroinflammation"},{"key":"e_1_3_4_7_2","first-page":"1","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"25","author":"Patone M.","year":"2021","unstructured":"Patone M., Handunnetthi L., Saatci D., Pan J., Katikireddi S.V., Razvi S. et al: Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med 2021 Oct; 25: 1.","journal-title":"Nat Med"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","unstructured":"Rao SJ Khurana S Murthy G Dawson ET Jazebi N Haas CJ. A case of Guillain\u2013Barre syndrome following Pfizer COVID-19 vaccine [Internet]. Vol. 11 Journal of Community Hospital Internal Medicine Perspectives. 2021. p. 597\u2013600. Available from: 10.1080\/20009666.2021.1954284.","DOI":"10.1080\/20009666.2021.1954284"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"e244125","DOI":"10.1136\/bcr-2021-244125","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 vaccination","volume":"14","author":"McKean N.","year":"2021","unstructured":"McKean N. and Chircop C.: Guillain-Barr\u00e9 syndrome after COVID-19 vaccination. BMJ Case Reports CP 2021; 14: e244125.","journal-title":"BMJ Case Reports CP"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1074"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17031035","article-title":"Network-based bioinformatics approach to identify molecular biomarkers for type 2 diabetes that are linked to the progression of neurological diseases","volume":"17","author":"Rahman M.H.","year":"2020","unstructured":"Rahman M.H., Peng S., Hu X., Chen C., Rahman M.R., Uddin S. et al: Network-based bioinformatics approach to identify molecular biomarkers for type 2 diabetes that are linked to the progression of neurological diseases. Int J Environ Res Public Health 2020; 17.","journal-title":"Int J Environ Res Public Health"},{"key":"e_1_3_4_12_2","first-page":"1","article-title":"Gene Ontology annotations: what they mean and where they come from","volume":"9","author":"Hill D.P.","year":"2008","unstructured":"Hill D.P., Smith B., McAndrews-Hill M.S. and Blake J.A.: Gene Ontology annotations: what they mean and where they come from. BMC Bioinf 2008 Apr 29; 9: 1.","journal-title":"BMC Bioinf"},{"key":"e_1_3_4_13_2","unstructured":"Mirdita M Ovchinnikov S Steinegger M. ColabFold - Making protein folding accessible to all [Internet]. Available from: 10.1101\/2021.08.15.456425."},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/bioinformatics\/bti125","article-title":"Protein homology detection by HMM-HMM comparison","volume":"21","author":"S\u00f6ding J.","year":"2005","unstructured":"S\u00f6ding J.: Protein homology detection by HMM-HMM comparison. Bioinformatics 2005; 21: 951.","journal-title":"Bioinformatics"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa379"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-9-1"},{"key":"e_1_3_4_17_2","article-title":"Proteome profile of peripheral myelin in healthy mice and in a neuropathy model","volume":"9","author":"Siems S.B.","year":"2020","unstructured":"Siems S.B., Jahn O., Eichel M.A., Kannaiyan N., Wu L.M.N., Sherman D.L. et al: Proteome profile of peripheral myelin in healthy mice and in a neuropathy model. Elife [Internet] 2020; 9.","journal-title":"Elife [Internet]"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fncel.2020.00239","article-title":"The CNS myelin proteome: deep profile and persistence after post-mortem delay","volume":"19","author":"Jahn O.","year":"2020","unstructured":"Jahn O., Siems S.B., Kusch K., Hesse D., Jung R.B., Liepold T. et al: The CNS myelin proteome: deep profile and persistence after post-mortem delay. Front Cell Neurosci 2020; 19: 239.","journal-title":"Front Cell Neurosci"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04319.x"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00517-1"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/jvi.59.3.735-739.1986","article-title":"Enhanced susceptibility to cytotoxic T lymphocytes of target cells isolated from virus-infected or interferon-treated mice","volume":"59","author":"Bukowski J.F.","year":"1986","unstructured":"Bukowski J.F. and Welsh R.M.: Enhanced susceptibility to cytotoxic T lymphocytes of target cells isolated from virus-infected or interferon-treated mice. J Virol 1986; 59: 735.","journal-title":"J Virol"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2010.00897.x"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3279"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/psc.2419"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001831"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","unstructured":"Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Reports Medicine. 2021;2(2):100204.","DOI":"10.1016\/j.xcrm.2021.100204"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","unstructured":"Seil FJ. Myelin Antigens and Antimyelin Antibodies. Antibodies (Basel) [Internet]. 2018;7(1). Available from: 10.3390\/antib7010002.","DOI":"10.3390\/antib7010002"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"R418","DOI":"10.1016\/j.cub.2006.05.010","article-title":"Myelin biogenesis: sorting out protein trafficking","volume":"16","author":"Anitei M.","year":"2006","unstructured":"Anitei M. and Pfeiffer S.E.: Myelin biogenesis: sorting out protein trafficking. Curr Biol 2006; 16: R418.","journal-title":"Curr Biol"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1700220"},{"key":"e_1_3_4_30_2","unstructured":"Jurtz V Paul S Andreatta M Marcatili P Peters B Nielsen M. NetMHCpan 4.0: Improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data [Internet]. Available from: 10.1101\/149518."},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v32.i4.50"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni835"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108426","article-title":"On the molecular determinants of the SARS-CoV-2 attack","volume":"215","author":"Kanduc D.","year":"2020","unstructured":"Kanduc D. and Shoenfeld Y.: On the molecular determinants of the SARS-CoV-2 attack. Clin Immunol 2020; 215: 108426.","journal-title":"Clin Immunol"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1709"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.02.002"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600771"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00808-x"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.664664","article-title":"Autoimmune disorders of the nervous system: pathophysiology, clinical features, and therapy","author":"Bhagavati S.","year":"2021","unstructured":"Bhagavati S.: Autoimmune disorders of the nervous system: pathophysiology, clinical features, and therapy. Front Neurol 2021; .","journal-title":"Front Neurol"},{"key":"e_1_3_4_39_2","article-title":"HLA-B*15:01 is associated with asymptomatic SARS-CoV-2 infection","author":"Augusto D.G.","year":"2021","unstructured":"Augusto D.G., Yusufali T., Peyser N.D., Butcher X., Marcus G.M., Olgin J.E. et al: HLA-B*15:01 is associated with asymptomatic SARS-CoV-2 infection. medRxiv 2021; .","journal-title":"medRxiv"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-017-1207-1","article-title":"The MHC locus and genetic susceptibility to autoimmune and infectious diseases","volume":"18","author":"Matzaraki V.","year":"2017","unstructured":"Matzaraki V., Kumar V., Wijmenga C. and Zhernakova A.: The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol 2017; 18: 1.","journal-title":"Genome Biol"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.260"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani A.","year":"2020","unstructured":"Vojdani A. and Kharrazian D.: Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 2020; 217: 108480.","journal-title":"Clin Immunol"},{"key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neures.2014.09.010","article-title":"Binding specificity of anti-HNK-1 IgM M-protein in anti-MAG neuropathy: possible clinical relevance","volume":"91","author":"Hamada Y.","year":"2015","unstructured":"Hamada Y., Hirano M., Kuwahara M., Samukawa M., Takada K., Morise J. et al: Binding specificity of anti-HNK-1 IgM M-protein in anti-MAG neuropathy: possible clinical relevance. Neurosci Res 2015; 91: 63.","journal-title":"Neurosci Res"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.617089","article-title":"Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases","author":"Vojdani A.","year":"2021","unstructured":"Vojdani A., Vojdani E. and Kharrazian D.: Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol 2021; .","journal-title":"Front Immunol"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-020-09152-6"},{"key":"e_1_3_4_46_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrneurol.2014.260","article-title":"Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders [Internet]","volume":"11","author":"Stathopoulos P.","year":"2015","unstructured":"Stathopoulos P., Alexopoulos H. and Dalakas M.C.: Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders [Internet]. Nat Rev Neurol 2015; 11: 143.","journal-title":"Nat Rev Neurol"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00033.2013"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0402-6"},{"key":"e_1_3_4_49_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10072-019-04089-7","article-title":"Anti-MAG IgM: differences in antibody tests and correlation with clinical findings","volume":"41","author":"Mat\u00e0 S.","year":"2020","unstructured":"Mat\u00e0 S., Ambrosini S., Saccomanno D., Biagioli T., Carpo M., Amantini A. et al: Anti-MAG IgM: differences in antibody tests and correlation with clinical findings. Neurol Sci 2020; 41: 365.","journal-title":"Neurol Sci"},{"key":"e_1_3_4_50_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577127","article-title":"Association of variability in antibody binding affinity with a clinical course of anti-MAG neuropathy","volume":"15","author":"Matsui T.","year":"2020","unstructured":"Matsui T., Hamada Y., Kuwahara M., Morise J., Oka S., Kaida K. et al: Association of variability in antibody binding affinity with a clinical course of anti-MAG neuropathy. J Neuroimmunol 2020; 15: 577127.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419"},{"key":"e_1_3_4_52_2","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00415-019-09367-0","article-title":"Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathies","volume":"266","author":"Delmont E.","year":"2019","unstructured":"Delmont E., Attarian S., Antoine J.C., Paul S., Camdessanch\u00e9 J.P., Grapperon A.M. et al: Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathies. J Neurol 2019; 266: 1973.","journal-title":"J Neurol"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.12.002"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-017-0515-7"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2006.06.014"},{"key":"e_1_3_4_56_2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/jnnp-2020-323522","article-title":"Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke","volume":"91","author":"Al Saiegh F.","year":"2020","unstructured":"Al Saiegh F., Ghosh R., Leibold A., Avery M.B., Schmidt R.F., Theofanis T. et al: Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry 2020; 91: 846.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_4_57_2","article-title":"The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens","author":"Duan L.","year":"2020","unstructured":"Duan L., Zheng Q., Zhang H., Niu Y., Lou Y., The W.H. et al: The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens. Front Immunol 2020; .","journal-title":"Front Immunol"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2550-z"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010067"},{"key":"e_1_3_4_60_2","first-page":"21267432","article-title":"Reduced neutralization of SARS-CoV-2 omicron variant by vaccine sera and monoclonal antibodies","volume":"12","author":"Wilhelm A.","year":"2021","unstructured":"Wilhelm A., Widera M., Grikscheit K., Toptan T., Schenk B., Pallas C. et al: Reduced neutralization of SARS-CoV-2 omicron variant by vaccine sera and monoclonal antibodies. medRxiv 2021; 12: 21267432.","journal-title":"medRxiv"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S200103702200469X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S200103702200469X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2022.10.022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T15:47:31Z","timestamp":1779032851000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2022.10.022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":59,"alternative-id":["10.1016\/j.csbj.2022.10.022"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2022.10.022","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Mimicry of SARS-CoV-2 Spike Protein in the Nervous System: A Bioinformatics Approach","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2022.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}